Aptamer appoints three new members to scientific board
6th Dec 2024 13:30
(Sharecast News) - Aptamer Group announced the appointment of three new members to its scientific advisory board on Friday, as it advanced the commercialisation of its 'Optimer' binders for life sciences applications.
Read moreAptamer reports progress since July fundraise
29th Nov 2024 10:46
(Sharecast News) - Aptamer Group, the developer of 'Optimer' binders for the life sciences industry, flagged solid operational progress in an update on Friday, reporting that since its £2.6m fundraising in July, it had achieved cost-reduction targets, streamlined scientific production, and executed a new commercial growth strategy.
Read moreAptamer extends contract with Unilever
3rd Sep 2024 08:06
(Sharecast News) - Custom antibody alternatives business Aptamer said on Tuesday that it has extended its contract with household goods giant Unilever to progress its Optimer asset for deodorant development.
Read moreAptamer reports success in ongoing work with Unilever
8th Jul 2024 10:49
(Sharecast News) - Aptamer Group, a developer of novel 'Optimer' binders for the life sciences industry, updated the market on its ongoing partnership with Unilever on Monday, aimed at creating Optimer binders for use in cosmetic applications.
Read moreAptamer enters partnership with Microsaic Systems
14th Jun 2024 14:15
(Sharecast News) - Aptamer Group announced a partnership with Microsaic Systems on Friday, to develop a panel of Optimer binders for integration into Microsaic's water testing system.
Read moreAptamer sales pipeline 'strong', more than £3m in advanced discussions
13th May 2024 10:47
(Sharecast News) - Life sciences business Aptamer said on Monday that its current sales pipeline was "strong", with over £3.0m in advanced stage discussions.
Read moreAptamer applies for patent over binder sequences developed with Unilever
8th Apr 2024 11:25
(Sharecast News) - Aptamer Group announced the submission of a patent application safeguarding newly-crafted Optimer binder sequences on Monday.
Read moreAptamer reports decent technical, commercial progress
15th Dec 2023 11:06
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
Read moreAptamer inks £0.55m agreement with biotech firm
14th Dec 2023 16:43
(Sharecast News) - Aptamer Group announced a significant agreement with a biotechnology company on Thursday, focussed on genetic medicines.
Read moreAptamer secures two contracts with big pharma firm
17th Aug 2023 15:51
(Sharecast News) - Life sciences company Aptamer Group has secured two new contracts with one of the world's top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to £0.22m.
Read moreAptamer announces four significant new contracts
7th Jul 2023 13:40
(Sharecast News) - Life sciences company Aptamer Group announced a significant update on recent contract wins on Friday, totalling up to £0.51m over the next six months.
Read moreAptamer warns on profits amid slow pipeline conversion
5th May 2023 15:48
(Sharecast News) - Life sciences company Aptamer Group said in a trading update on Friday that revenue in the 10 months ended 30 April totalled around £1.4m.
Read moreAptamer warns on FY revenues
3rd Jan 2023 08:36
(Sharecast News) - Biotech company Aptamer Group warned on Tuesday that while full-year revenues may fall short of market expectations, they were still likely to come in "materially ahead" of the level achieved in the previous financial year.
Read more